Chronic myeloid leukemia (CML) is a type of blood cancer that starts in the bone marrow. It causes the body to produce too many white blood cells. Some people discover they have CML during a routine blood test, even when they feel completely fine.
Hearing the word leukemia can be frightening. But CML has changed a lot in recent years. Targeted medicines can control the disease in many patients, and people who respond well to treatment can often continue their daily activities with regular medical follow-up.
Early diagnosis, the right medicine, and consistent monitoring all matter.
If you have an unexplained high white blood cell count or have been diagnosed with CML, consulting a Hematologist and Hemato-Oncologist in Nagpur can help you understand your reports and treatment options.
Here are seven important facts about CML, from its early signs to diagnosis, treatment, and long-term care.
What Is Chronic Myeloid Leukemia?
Chronic myeloid leukemia is also called chronic myelogenous leukemia. It develops in the blood-forming cells of the bone marrow and usually progresses more slowly than acute leukemia, particularly during its chronic phase.
In most cases, CML is associated with a genetic change that creates the BCR::ABL1 fusion gene. This gene produces an abnormal protein that sends signals telling certain white blood cells to grow and multiply.
As these cells build up, they can affect normal blood cell production and may cause the spleen to enlarge.
CML is not usually inherited from a parent. The genetic change generally develops during a person’s lifetime.
7 Important Facts About CML Diagnosis and Treatment
1. CML May Not Cause Noticeable Symptoms in the Early Stages
One of the challenging things about CML is that it may not cause clear symptoms at first. Some people learn about the condition after a routine complete blood count shows an unusually high white blood cell count.
When symptoms do appear, they may develop gradually.
Common signs include:
- Persistent tiredness or weakness
- Unexplained weight loss
- Night sweats
- Fever without an obvious cause
- A feeling of fullness or discomfort on the left side of the abdomen
- Loss of appetite
- Unusual bleeding or bruising in some patients
- Bone discomfort in some cases
An enlarged spleen may make you feel full after eating only a small amount of food. You might also notice discomfort below your left ribs.
These symptoms do not automatically mean you have leukemia. Infections and other medical conditions can cause similar changes.
Still, if your blood tests repeatedly show a high white blood cell count, do not ignore the finding. A Hematologist and Hemato-Oncologist in Nagpur can review your reports and decide whether further testing is needed.
2. The BCR::ABL1 Gene Helps Doctors Confirm CML
A high white blood cell count alone cannot confirm CML. Doctors need to identify the genetic change associated with the disease.
Most cases of CML involve the Philadelphia chromosome, which forms when parts of chromosomes 9 and 22 exchange genetic material. This change creates the BCR::ABL1 fusion gene.
The abnormal gene produces a protein called BCR::ABL1 tyrosine kinase. It encourages affected blood cells to grow when they should not.
Doctors may use several tests to confirm the diagnosis.
Complete blood count
A CBC measures your white blood cells, red blood cells, haemoglobin, and platelets. The results help doctors identify unusual blood cell patterns.
Peripheral blood smear
A laboratory specialist examines blood cells under a microscope. This can reveal immature white blood cells and other changes that support further investigation.
BCR::ABL1 testing
Molecular testing, often using reverse transcription polymerase chain reaction (RT-PCR), looks for the BCR::ABL1 genetic marker. It can also measure the amount of this marker during treatment.
Bone marrow examination
Doctors may recommend bone marrow aspiration and biopsy to assess blood-forming cells, examine chromosome changes, and establish a baseline for treatment.
Not every patient needs every test in the same way. Your specialist will choose tests based on your blood results, symptoms, and medical history.
3. CML Has Different Phases, and Each Needs Careful Assessment
Doctors classify CML into phases based on the number of immature cells, called blasts, and other clinical and laboratory findings.
The phase helps guide treatment decisions.
Chronic phase
This is the phase in which most patients receive their diagnosis. The disease generally progresses more slowly, and targeted medicines often work well.
Accelerated phase
The disease shows signs of progression. Blood cell patterns and other findings may become more concerning, and treatment may need to be adjusted.
Blast phase
In this advanced phase, a large number of immature cells accumulate. The disease can behave more like an acute leukemia and usually requires more intensive treatment.
The precise classification criteria can vary by clinical guideline. Your doctor will interpret your results using the appropriate criteria rather than relying on one test alone.
Why does the phase matter? Because treatment that works well in chronic-phase CML may not be enough when the disease has progressed.
This is one reason to seek specialist assessment soon after a diagnosis rather than delaying follow-up.
4. Targeted Medicines Are the Main Treatment for Many Patients
CML treatment has changed significantly with the development of targeted medicines called tyrosine kinase inhibitors (TKIs).
These medicines block the abnormal BCR::ABL1 protein that drives the disease. This helps reduce the growth of leukemia cells.
Commonly used TKIs include:
- Imatinib
- Dasatinib
- Nilotinib
- Bosutinib
- Asciminib, which works through a different mechanism from the other listed medicines
The choice depends on several factors, including the phase of CML, other health conditions, possible side effects, drug interactions, treatment goals, and the patient’s response.
Many people with chronic-phase CML take oral medication over the long term. Doctors monitor blood tests to check whether treatment is working and whether side effects need attention.
Possible side effects vary by medicine. They may include nausea, fluid retention, muscle cramps, changes in blood counts, or changes in liver function. Some medicines also carry specific risks that require monitoring.
Do not stop or change your medicine because you feel better or experience a side effect. Contact your treating specialist, who can advise you on safe ways to manage the problem or whether a different treatment is needed.
For many patients, taking the medicine as prescribed is a key part of keeping CML under control.
5. Regular BCR::ABL1 Testing Shows Whether Treatment Is Working
Starting treatment is only one part of CML care. Doctors also need to know how your body is responding.
A quantitative BCR::ABL1 PCR test measures the level of the genetic marker in your blood. If treatment is working, the level usually falls over time.
Your specialist may monitor:
- White blood cell and platelet counts
- Haemoglobin levels
- BCR::ABL1 levels on the International Scale
- Side effects and medicine tolerance
- Symptoms that could suggest disease progression
Molecular testing is commonly performed about every three months after treatment starts, particularly while doctors assess the early response. The schedule may change once the response becomes stable or if results raise concerns.
Doctors look for specific response milestones. For example, a BCR::ABL1 level of 0.1% or lower on the International Scale is generally used to define a major molecular response.
One result should not be interpreted in isolation. Your doctor will consider the trend, how long you have been taking the medicine, missed doses, and other clinical findings.
If the level does not fall as expected or starts rising, the specialist may check adherence, review possible drug interactions, or order additional testing for resistance.
Regular monitoring helps doctors make decisions based on measurable results rather than symptoms alone.
6. Most Patients Do Not Need a Bone Marrow Transplant as Their First Treatment
A common concern after a CML diagnosis is whether a bone marrow transplant will be necessary.
For many patients diagnosed during the chronic phase, targeted medicines are the first treatment. A stem cell transplant is not routinely required at the start.
A transplant may be considered in selected situations, such as disease that does not respond to available medicines, significant treatment resistance, or progression to a more advanced phase.
A stem cell transplant replaces the patient’s blood-forming stem cells with healthy stem cells from a donor. It can offer long-term disease control and a potential cure, but it also carries serious risks.
These include infections, graft-versus-host disease, organ complications, and other transplant-related problems.
Doctors consider the patient’s age, overall health, disease phase, response to treatment, donor availability, and personal circumstances before recommending a transplant.
If your specialist mentions transplantation, ask why it is being considered, what alternatives are available, and what recovery may involve.
7. Long-Term Care and Daily Habits Matter
CML often requires long-term treatment and follow-up. Even when you feel well, the disease may still need treatment and monitoring.
A few practical habits can help you stay on track.
Take your medicine consistently
Follow the prescribed schedule. If you miss a dose or vomit after taking your medicine, ask your care team what to do rather than doubling the next dose on your own.
Attend follow-up appointments
Keep track of your CBC and BCR::ABL1 test dates. These results help your doctor assess treatment response and decide whether changes are needed.
Tell your doctor about other medicines
Some prescription medicines, over-the-counter products, and supplements can interact with CML treatment. Share a complete list with your specialist before starting anything new.
Pay attention to new symptoms
Report persistent fever, unusual bleeding, worsening abdominal discomfort, or new symptoms to your treating team. Seek urgent care for severe symptoms.
Look after your general health
Eat regular, balanced meals, stay physically active as your health allows, and get enough rest. These habits support general well-being, though they do not replace CML treatment.
Some patients who maintain a deep and stable molecular response for a suitable period may be assessed for treatment-free remission. This is not appropriate for everyone and should only be attempted under specialist supervision with close molecular monitoring. Never stop a TKI on your own.
When Should You Consult a Hematologist and Hemato-Oncologist in Nagpur?
Consider consulting a specialist if you have a persistently high white blood cell count, unexplained fatigue, night sweats, unexplained weight loss, or a blood test that suggests a possible blood disorder.
A specialist can help you:
- Understand your CBC and molecular test results
- Confirm the diagnosis and determine the phase of CML
- Discuss suitable targeted medicines
- Monitor your response to treatment
- Manage side effects and review possible drug interactions
- Explore further treatment options if the disease does not respond as expected
If you have already received a CML diagnosis, take your previous blood reports, medication list, and molecular test results to your appointment. These details can help your doctor understand how the condition has changed over time.
Frequently Asked Questions About CML
- Is chronic myeloid leukemia curable?
Targeted medicines can control CML for many years, and some patients achieve a deep molecular response. Selected patients may qualify for treatment-free remission under close medical supervision. A stem cell transplant can offer a potential cure in certain cases.
- Can a person with CML live a normal life?
Many people with chronic-phase CML continue working, studying, and managing everyday activities while receiving treatment. Their experience depends on their response to medicine, side effects, general health, and follow-up results.
- Does CML always cause symptoms?
No. Some people have no noticeable symptoms when doctors diagnose the condition. A routine blood test may reveal an unusually high white blood cell count, leading to further investigation.
- Which test confirms CML?
Doctors confirm CML by identifying the BCR::ABL1 fusion gene or the associated Philadelphia chromosome. They may use molecular testing, chromosome analysis, blood tests, and bone marrow examination as part of the diagnostic process.
- How long does CML treatment last?
Many patients take targeted medicines for years, often on a long-term basis. Selected patients who meet strict criteria may be considered for a supervised treatment-free remission attempt. The decision depends on their molecular response and other clinical factors.
